Biologic Imaging Contrast Agent Market

Biologic Imaging Contrast Agent Market contains market size and forecasts of Biologic Imaging Contrast Agent in global, including the following market information:

• Global Biologic Imaging Contrast Agent Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Biologic Imaging Contrast Agent Market Sales, 2017-2022, 2023-2028, (Kiloton)
• Global top five Biologic Imaging Contrast Agent companies in 2021 (%)

The global Biologic Imaging Contrast Agent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CT Contrast Reagents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biologic Imaging Contrast Agent include Bracco, Bayer HealthCare, Hengrui Medicine, GE Healthcare, YRPG, BeiLu Pharma, Guerbet and Starry Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Biologic Imaging Contrast Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biologic Imaging Contrast Agent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Biologic Imaging Contrast Agent Market Segment Percentages, by Type, 2021 (%)

• CT Contrast Reagents
• Magnetic Resonance Imaging (MRI) Contrast Reagents
• Ultrasound Contrast Reagents

Global Biologic Imaging Contrast Agent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Biologic Imaging Contrast Agent Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Biologic Imaging Contrast Agent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Biologic Imaging Contrast Agent Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Biologic Imaging Contrast Agent revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Biologic Imaging Contrast Agent revenues share in global market, 2021 (%)
• Key companies Biologic Imaging Contrast Agent sales in global market, 2017-2022 (Estimated), (Kiloton)
• Key companies Biologic Imaging Contrast Agent sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bracco
• Bayer HealthCare
• Hengrui Medicine
• GE Healthcare
• YRPG
• BeiLu Pharma
• Guerbet
• Starry Pharmaceutical